Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bristol-Myers Squibb Pharmaceutical Limited
Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 17/02/2012
PIL Etopophos 100mg Powder for Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/02/2012 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 11/11/2010 and displayed until 17/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 29/06/2010 and displayed until 11/11/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 27/01/2010 and displayed until 29/06/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 14/11/2000 and displayed until 27/01/2010
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  etoposide phosphate